Testosterone modulates gene expression pathways regulating nutrient accumulation, glucose metabolism and protein turnover in mouse skeletal muscle

International Journal of Andrology

Volumn 34, Issue 1, 2011, Pages 55-68

  Haren, M T ^a,b   Siddiqui, A M ^b   Armbrecht, H J ^a,b   Kevorkian, R T ^a,b   Kim, M J ^a,b   Haas, M J ^b   Mazza, A ^b   Kumar, Vijaya B ^a,b   Green, M ^b   Banks, W A ^a,b   Morley, J E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrogin 1; Glucose; Grb10; Interferon ; Interleukin 1 ; Skeletal muscle; Testosterone

Indexed keywords

ATROGIN 1; GLUCOSE; MESSENGER RNA; PHOSPHORYLASE KINASE; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; INSULIN SENSITIVITY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN TARGETING; SKELETAL MUSCLE;

ACETYLTRANSFERASES; ANIMALS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 3; GRB10 ADAPTOR PROTEIN; INTERFERON-GAMMA; INTERLEUKIN-1ALPHA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NUCLEAR PROTEINS; ORCHIECTOMY; PHOSPHORYLASE KINASE; PROTEINS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TESTOSTERONE;

EID: 78651325763     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2010.01061.x     Document Type: Article

References (56)

1. Axell AM, MacLean HE, Plant DR, Harcourt LJ, Davis JA, Jiminez M, Handelsman DJ, Lynch GS & Zajac JD. (2006) Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab 291, E506-E516.
2. Barton ER. (2006) The ABCs of IGF- I isoforms: impact on muscle hypertrophy and implications for repair. Appl Physiol Nutr Metab 31, 791-797.
3. Basu R, Dalla Man C, Campioni M, Basu A, Nair KS, Jensen MD, Khosla S, Klee G, Toffolo G, Cobelli C & Rizza R. (2007) Effect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care 30, 1972-1978.
4. Baumgartner RN, Waters DL, Gallagher D, Morley JE & Garry PJ. (1999) Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev 107, 123-136.
5. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A & Casaburi R. (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335, 1-7.
6. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N et al. (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281, E1172-E1181.
7. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al. (2004) A physical and functional map of the human TNF- alpha/NF- kappa B signal transduction pathway. Nat Cell Biol 6, 97-105.
8. Charalambous M, Smith FM, Bennett WR, Crew TE, Mackenzie F & Ward A. (2003) Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2- independent mechanism. Proc Natl Acad Sci USA 100, 8292-8297.
9. Crosson SM, Khan A, Printen J, Pessin JE & Saltiel AR. (2003) PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest 111, 1423-1432.
10. Dehoux M, Gobier C, Lause P, Bertrand L, Ketelslegers JM & Thiessen JP. (2007) IGF- I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK- 3beta pathways and inhibition of atrogin- 1 mRNA. Am J Physiol Endocrinol Metab 292, E145-E150.
11. Deval C, Mordier S, Obled C, Bechet D, Combaret L, Attaix D & Ferrara M. (2001) Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Biochem J 360, 143-150.
12. Edstrom E, Altun M, Hagglund M & Ulfhake B. (2006) Atrogin- 1/MAFbx and MuRF1 are downregulated in aging- related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci 61, 663-674.
13. Fan W, Yanase T, Nomura M, Okabe T, Goto K, Sato T, Kawano H, Kato S & Nawata H. (2005) Androgen receptor null male mice develop late- onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54, 1000-1008.
14. Ferrando AA, Sheffield- Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ. (2002) Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab 282, E601-E607.
15. Gentile MA, Nantermet PV, Vogel RL, Phillips R, Holder D, Hodor P, Cheng C, Dai H, Freedman LP & Ray WJ. (2010) Androgen mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF- 1, MGF and induction of beta- catenin. J Mol Endocrinol 44, 55-73.
16. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD & Goldspink G. (2004) The effect of recombinant human growth hormone and resistance training on IGF- I mRNA expression in the muscles of elderly men. J Physiol 555, 231-240.
17. van Harmelen V, Ryden M, Sjolin E & Hoffstedt J. (2007) A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression. J Lipid Res 48, 201-206.
18. Hosack DA, Dennis G, Jr, Sherman BT, Lane HC & Lempicki RA. (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4, R70.
19. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D et al. (2007) DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35 (Web Server Issue), W169-W175.
20. Huffman TA, Mothe- Satney I & Lawrence JC, Jr. (2002) Insulin- stimulated phosphorylation of lipin mediated by the mammalian target of rapamycin. Proc Natl Acad Sci USA 99, 1047-1052.
21. Hyde R, Peyrollier K & Hundal HS. (2002) Insulin promotes the cell surface recruitment of the SAT2/ATA2 system A amino acid transporter from an endosomal compartment in skeletal muscle cells. J Biol Chem 277, 13628-13634.
22. Kaspar BK, Frost LM, Christian L, Umapathi P & Gage FH. (2005) Synergy of insulin- like growth factor- 1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 57, 649-655.
23. Kenny AM, Prestwood KM, Gruman CA, Marcello KM & Raisz LG. (2001) Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 56, M266-M272.
24. Kim YB, Peroni OD, Aschenbach WG, Minokoshi Y, Kotani K, Zisman A, Khan CR, Goodyear LJ & Kahn BB. (2005) Muscle- specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Mol Cell Biol 25, 9713-9723.
25. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ & McKinlay JB. (2006) Low sex hormone- binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91, 843-850.
26. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, Salonen R & Salonen JT. (2004) Testosterone and sex hormone- binding globulin predict the metabolic syndrome and diabetes in middle- aged men. Diabetes Care 27, 1036-1041.
27. Labrie F, Luu- The V, Calvo E, Martel C, Cloutier J, Gauthier S, Belleau P, Morissette J, Levesque MH & Labrie C. (2005) Tetrahydrogestrinone induces a genomic signature typical of a potent anabolic steroid. J Endocrinol 184, 427-433.
28. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, Lin HC, Yancopoulos GD & Glass DJ. (2005) Insulin- like growth factor- 1 (IGF- 1) inversely regulates atrophy- induced genes via the phosphatidylinositol 3kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 280, 2737.
29. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD & Chang C. (2005) Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54, 1717-1725.
30. Ma Y, Toth B, Keeton AB, Holland LT, Chaudry IH & Messina JL. (2004) Mechanisms of hemorrhage- induced hepatic insulin resistance: role of tumor necrosis factor- alpha. Endocrinology 145, 5168-5176.
31. Magee JA, Chang LW, Stormo GD & Milbrandt J. (2006) Direct, androgen receptor- mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 147, 590-598.
32. Matsukura U, Okitani A, Nishimuro T & Kato H. (1981) Mode of degradation of myofibrillar proteins by an endogenous protease, cathepsin L. Biochim Biophys Acta 662, 41-47.
33. Monks DA, Kopachik W, Breedlove SM & Jordan CL. (2006) Anabolic responsiveness of skeletal muscles correlates with androgen receptor protein but not mRNA. Can J Physiol Pharmacol 84, 273-277.
34. Montaino M, Flanagan JN, Jiang L, Sebastiani P, Rarick M, LeBrasseur NK, Morris CA, Jasuja R & Bhasin S. (2007) Transcriptional profiling of testosterone- regulated genes in the skeletal muscle of human immunodeficiency virus- infected men experiencing weight loss. J Clin Endocrinol Metab 92, 2793-2802.
35. Morley JE, Baumgartner RN, Roubenoff R, Mayer J & Nair KS. (2001) Sarcopenia. J Lab Clin Med 137, 231-243.
36. Page ST, Amory JK, Bowman FD, Anawalt BD, Matsumoto AM, Bremner WJ & Tenover JL et al. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 90, 1502-1510.
37. Parker GE, Pederson PA, Obayashi M, Schroeder JM, Harris RA & Roach PJ. (2006) Gene expression profiling of mice with genetically modified muscle glycogen content. Biochem J 395, 137-145.
38. Pavlidis P. (2003) Using ANOVA for gene selection from microarray studies of the nervous system. Methods 31, 282-289.
39. Phan J & Reue K. (2005) Lipin, a lipodystrophy and obesity gene. Cell Metab 1, 73-83.
40. Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR & Andres R. (2007) Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 92, 3568-3572.
41. Sato T, Matasumoto T, Yamada T, Watanabe T, Kawano H & Kato S. (2003) Late onset of obesity in male androgen receptor- deficient (AR KO) mice. Biochem Biophys Res Commun 300, 167-171.
42. Sherman BT, Huang de W, Tan Q, Guo Y, Bour S, Liu D, Stephens R, Baseler MW, Lane HC & Lempicki RA. (2007) DAVID Knowledgebase: a gene- centered database integrating heterogeneous gene annotation resources to facilitate high- throughput gene functional analysis. BMC Bioinformatics 8, 426.
43. Sih R, Morley JE, Kaiser FE, Perry HM, III, Patrick P & Ross C. (1997) Testosterone replacement in older hypogonadal men: a 12- month randomized controlled trial. J Clin Endocrinol Metab 82, 1661-1667.
44. Singh R, Bhasin S, Braga M, Artaza JN, Pervin S, Taylor WE, Krishnan V, Sinha SK, Rajavashisth TB & Jasuja R. (2009) Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/beta- catenin and follistatin/transforming growth factor- beta signaling pathways. Endocrinology 150, 1259-1268.
45. Smith FM, Holt LJ, Garfield AS, Charalambous M, Koumanov F, Perry M et al. (2007) Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis and insulin signalling during post- natal life. Mol Cell Biol 27, 5871-5886.
46. Snyder PJ, Peachet H, Hannoush P, Berlin JA, Loh L, Lenrow DA et al. (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84, 2647-2653.
47. Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A et al. (2000) Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85, 2670-2677.
48. Stellato RK, Feldman HA, Hamdy O, Horton ES & McKinlay JB. (2000) Testosterone, sex hormone- binding globulin, and the development of type 2 diabetes in middle- aged men: prospective results from the Massachusetts Male Aging Study. Diabetes Care 23, 490-494.
49. Thomas DR. (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26, 389-399.
50. Towbin H, Staehelin T & Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76, 4350-4354.
51. Urban RJ. (1999) Effects of testosterone and growth hormone on muscle function. J Lab Clin Med 134, 7-10.
52. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T & Berman N. (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85, 2839-2853.
53. Weinstein JN, Myero TG, O'Connor PM, Friend SH, Fornance AJ Jr., Kohn KW et al. (1997) An information- intensive approach to the molecular pharmacology of cancer. Science 275, 343-349.
54. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P & Morley JE. (2003) Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low- normal gonadal status. J Gerontol A Biol Sci Med Sci 58, 618-625.
55. Xu J, Lee WN, Phan J, Saad MF, Reue K & Kurland JJ. (2006) Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes 55, 3429-3438.
56. Yoshioka M, Boivin A, Ye P, Labrie F & St- Amand J. (2006) Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression. J Mol Endocrinol 36, 247-259.